DJIA 17,672.60 -141.38 -0.79%
NASDAQ 4,757.88 7.48 0.16%
S&P 500 2,051.82 -11.33 -0.55%
market minute promo

Hospira, Inc. (NYSE: HSP)

65.39 0.65 (1.00%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

HSP $65.39 1.00%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $64.67
Previous Close $64.74
Daily Range $64.55 - $65.58
52-Week Range $40.41 - $65.58
Market Cap $11.1B
P/E Ratio 33.20
Dividend (Yield) $0.00 (0.0%)
Volume 1,100,662
Average Daily Volume 992,749
Current FY EPS $2.46





Hospira, Inc. (HSP) Description

A specialty pharmaceutical and medication delivery company that is focused on products that improve the productivity, safety and efficacy of patient care. Website:

News & Commentary

Why Johnson & Johnson's Stock Could Crater in 2015

Johnson & Johnson is facing some serious threats to its top line this year. Here's what investors need to know going forward.

Hospira's Plum 36O Infusion System Gets FDA Clearance - Analyst Blog

Feeling Good With This Med Company

Hospira Receives FDA Clearance for Plum 360 Infusion System

Hospira Submits Retacrit Regulatory Application to the FDA - Analyst Blog

Insider Trading Alert - VICL, TIPT And HSP Traded By Insiders

5 Predictions for Biotechnology Stocks in 2015

Celgene Corp, Alkermes, GW Pharmaceuticals, Gilead Sciences, and Hospira should all be on investors radar in 2015.

Orphan Drug Company NPS Pharmaceuticals May Find Few Buyers

Hospira's Dyloject Cleared in the U.S. for Pain Management - Analyst Blog

Epirus Biopharma: A High Risk/High Reward Biosimilar Investment

See More HSP News...

HSP's Top Competitors

HSP $65.39 (1.00%)
Current stock: HSP
COV $108.07 (1.52%)
Current stock: COV
$0.00 (0.00%)
Current stock:
BAX $71.43 (-1.15%)
Current stock: BAX